Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion

[1]  David L. Williams,et al.  Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism1 , 2007, The Journal of Immunology.

[2]  O. Hurtado,et al.  Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke , 2007, Circulation.

[3]  Jie Cui,et al.  Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. , 2007, Biochemical and biophysical research communications.

[4]  H. Kato,et al.  Immunohistochemical Study on Distribution of NF-κB and p53 in Gerbil Hippocampus after Transient Cerebral Ischemia: Effect of Pitavastatin , 2007, Metabolic Brain Disease.

[5]  A. Shimamoto,et al.  Toll-like receptor 4 mediates lung ischemia-reperfusion injury. , 2006, The Annals of thoracic surgery.

[6]  K. Tracey,et al.  HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.

[7]  Jong-sang Park,et al.  HMGB1, a Novel Cytokine-Like Mediator Linking Acute Neuronal Death and Delayed Neuroinflammation in the Postischemic Brain , 2006, The Journal of Neuroscience.

[8]  David L. Williams,et al.  The development of a novel mouse model of transient global cerebral ischemia , 2006, Neuroscience Letters.

[9]  P. Chan,et al.  Activation of the Akt/GSK3β Signaling Pathway Mediates Survival of Vulnerable Hippocampal Neurons after Transient Global Cerebral Ischemia in Rats , 2006 .

[10]  David L. Williams,et al.  Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.

[11]  E. Abraham,et al.  High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.

[12]  David L. Williams,et al.  Blocking the MyD88-dependent pathway protects the myocardium from ischemia/reperfusion injury in rat hearts. , 2005, Biochemical and biophysical research communications.

[13]  R. Jope,et al.  Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3 , 2005, Nature Immunology.

[14]  Chul-woo Yang,et al.  Ischemia-Reperfusion Injury Activates Innate Immunity in Rat Kidneys , 2005, Transplantation.

[15]  Sumana Chakravarty,et al.  Toll-Like Receptor 4 on Nonhematopoietic Cells Sustains CNS Inflammation during Endotoxemia, Independent of Systemic Cytokines , 2005, The Journal of Neuroscience.

[16]  Qi Chen,et al.  [Role of MyD88-dependent nuclear factor-kappaB signaling pathway in the development of cardiac hypertrophy in vivo]. , 2005, Zhonghua yi xue za zhi.

[17]  Ryan M. O’Connell,et al.  Cutting Edge: TLR4 Activation Mediates Liver Ischemia/Reperfusion Inflammatory Response via IFN Regulatory Factor 3-Dependent MyD88-Independent Pathway1 , 2004, The Journal of Immunology.

[18]  P. Kubes,et al.  TLR4 Contributes to Disease-Inducing Mechanisms Resulting in Central Nervous System Autoimmune Disease1 , 2004, The Journal of Immunology.

[19]  H. Lassmann,et al.  Ischemia Leads to Apoptosis—and Necrosis‐like Neuron Death in the Ischemic Rat Hippocampus , 2004, Brain pathology.

[20]  K. Lambertsen,et al.  A Role for Interferon‐Gamma in Focal Cerebral Ischemia in Mice , 2004, Journal of neuropathology and experimental neurology.

[21]  R. Jope,et al.  The glamour and gloom of glycogen synthase kinase-3. , 2004, Trends in biochemical sciences.

[22]  E. Lo,et al.  Role of Matrix Metalloproteinases in Delayed Neuronal Damage after Transient Global Cerebral Ischemia , 2004, The Journal of Neuroscience.

[23]  A. Wood,et al.  Temporal assessment of caspase activation in experimental models of focal and global ischemia , 2003, Brain Research.

[24]  Pamela L. Follett,et al.  Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  U. Kuhnt,et al.  Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections , 2003, Neuroscience Letters.

[26]  K. Vuori,et al.  Phosphatidylinositol 3‐kinase is involved in Toll‐like receptor 4‐mediated cytokine expression in mouse macrophages , 2003, European journal of immunology.

[27]  R. Ravid,et al.  Broad Expression of Toll‐Like Receptors in the Human Central Nervous System , 2002, Journal of neuropathology and experimental neurology.

[28]  F. Tortella,et al.  Quantitative Real-Time RT—PCR Analysis of Inflammatory Gene Expression Associated with Ischemia—Reperfusion Brain Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  A. Shuaib,et al.  Involvement of inflammatory cytokines in central nervous system injury , 2002, Progress in Neurobiology.

[30]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[31]  M. J. Cody,et al.  TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.

[32]  K. Jin,et al.  Fas (CD95) May Mediate Delayed Cell Death in Hippocampal CA1 Sector after Global Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  C. J. Chen,et al.  Association of immune responses and ischemic brain infarction in rat , 2001, Neuroreport.

[34]  H. Brightbill,et al.  Toll‐like receptors: molecular mechanisms of the mammalian immune response , 2000, Immunology.

[35]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[36]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[37]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  I. Herr,et al.  CD95 Ligand (Fas-L/APO-1L) and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Mediate Ischemia-Induced Apoptosis in Neurons , 1999, The Journal of Neuroscience.

[39]  Markus Schwaninger,et al.  NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.

[40]  C. Coutelle,et al.  In utero gene therapy: The case for , 1999, Nature Medicine.

[41]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[42]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[43]  R. Willette,et al.  Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. , 1997, Stroke.

[44]  Y. Uchiyama,et al.  Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  D. Maślińska,et al.  Toll-like receptors in rat brains injured by hypoxic-ischaemia or exposed to staphylococcal alpha-toxin. , 2004, Folia neuropathologica.

[46]  J. Losy,et al.  [Cytokines in clinical and experimental ischemic stroke]. , 2004, Neurologia i neurochirurgia polska.

[47]  S. Akira,et al.  Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. , 2002, International immunology.

[48]  S. Ghosh,et al.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. , 2001, The Journal of clinical investigation.